PRP wrist study pulled before it even started
NCT ID NCT03830775
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study planned to test whether a platelet-rich plasma (PRP) injection, made from a patient's own blood, could help heal a common wrist ligament injury called TFCC tear. The trial was designed to compare PRP against a placebo in adults with MRI-confirmed tears. However, the study was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- platelet-rich plasma (PRP) injection
- What this could lead to
- If it had worked, this could have pointed toward a non-surgical treatment for common wrist ligament injuries.
- What could go wrong
- The trial was withdrawn before enrolling anyone, so no data exist. PRP is still unproven for this condition, and results from other joints vary widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRP are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lola Norton
El Paso, Texas, 79903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI mouse could give Pain-Free computing to millions with hand injuries
- New wrist scanner could slash radiation and speed up 3D imaging
- Could stem cells from shoulder tissue boost rotator cuff healing?
- ER wrist reset may be unnecessary for some breaks
- Simple splint might ease wrist fracture pain in the ER
- Hand rehab revolution? early data may predict recovery months ahead